Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Curtis Cooper

Showing results (1-10 of 267) with videos related to

Pageof 27
Sort By:
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|June 19, 2010
Viral response to specifically targeted antiviral therapy for hepatitis C and the implications for treatment successCurtis Cooper
The Lancet. Gastroenterology & Hepatology|April 27, 2017
Rapid HCV RNA testing: removing the final obstacle to eliminationCurtis Cooper
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 12, 2012
Hepatitis C treatment highlights from the 2011 American Association for the Study of Liver Disease meetingCurtis Cooper
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 3, 2019
Eliminating Hepatitis C (and the Unknowns) in the Human Immunodeficiency Virus CoinfectedCurtis Cooper
Journal of Emergency Nursing|July 30, 2004
A 6-month-old with bilateral swollen, painful, and deformed handsMaureen Curtis Cooper
Expert Opinion on Biological Therapy|October 27, 2007
Review of hepatitis B surface antigen-1018 ISS adjuvant-containing vaccine safety and efficacyMazin Barry, Curtis Cooper
HIV Clinical Trials|December 20, 2011
Vitamin D supplementation does not increase immunogenicity of seasonal influenza vaccine in HIV-infected adultsCurtis Cooper, Anona Thorne,
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|March 13, 2012
Reassessing the role for lamivudine in chronic hepatitis B infection: a four-year cohort analysisTahir Shaikh, Curtis Cooper
Drugs in R&D|May 7, 2008
A review of the role of CpG oligodeoxynucleotides as toll-like receptor 9 agonists in prophylactic and therapeutic vaccine development in infectious diseasesKaveri Gupta, Curtis Cooper
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 6, 2004
Clinical significance of hepatitis B core antibody positivity in HCV-infected and HCV/HIV coinfected individualsCurtis Cooper, Donald Kilby
Pageof 27

Showing results (1-10 of 267) with videos related to

Sort By:
Pageof 27
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|June 19, 2010
Viral response to specifically targeted antiviral therapy for hepatitis C and the implications for treatment successCurtis Cooper
The Lancet. Gastroenterology & Hepatology|April 27, 2017
Rapid HCV RNA testing: removing the final obstacle to eliminationCurtis Cooper
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 12, 2012
Hepatitis C treatment highlights from the 2011 American Association for the Study of Liver Disease meetingCurtis Cooper
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 3, 2019
Eliminating Hepatitis C (and the Unknowns) in the Human Immunodeficiency Virus CoinfectedCurtis Cooper
Journal of Emergency Nursing|July 30, 2004
A 6-month-old with bilateral swollen, painful, and deformed handsMaureen Curtis Cooper
Expert Opinion on Biological Therapy|October 27, 2007
Review of hepatitis B surface antigen-1018 ISS adjuvant-containing vaccine safety and efficacyMazin Barry, Curtis Cooper
HIV Clinical Trials|December 20, 2011
Vitamin D supplementation does not increase immunogenicity of seasonal influenza vaccine in HIV-infected adultsCurtis Cooper, Anona Thorne,
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|March 13, 2012
Reassessing the role for lamivudine in chronic hepatitis B infection: a four-year cohort analysisTahir Shaikh, Curtis Cooper
Drugs in R&D|May 7, 2008
A review of the role of CpG oligodeoxynucleotides as toll-like receptor 9 agonists in prophylactic and therapeutic vaccine development in infectious diseasesKaveri Gupta, Curtis Cooper
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 6, 2004
Clinical significance of hepatitis B core antibody positivity in HCV-infected and HCV/HIV coinfected individualsCurtis Cooper, Donald Kilby
Pageof 27